Aspirin And Extended-Release Dipyridamole

Summarized by Plex Health
Last Updated: 02 May 2022

Aspirin and extended-release dipyridamole is a combination of aspirin and dipyridamole, antiplatelet agents intended for oral administration. Each hard jelly capsule consists of 200 mg dipyridamole, USP in an extended-release kind and 25 mg aspirin USP, as an immediate-release sugar-coated tablet. Each pill covering consists of D&C Yellow # 10, gelatin, iron oxide red, iron oxide yellow, purified water, sodium lauryl sulfate and titanium dioxide. The imprinting inks include butyl alcohol, D&C Yellow # 10, dehydrated alcohol, FD&C Red # 40, isopropyl alcohol, povidone, propylene glycol, shellac, salt hydroxide and titanium dioxide. Dipyridamole, USP Dipyridamole, USP is an antiplatelet agent chemically called 2,2',2",2"'- [dinitrilo] -tetraethanol. Aspirin, USP The antiplatelet agent aspirin, USP is chemically recognized as benzoic acid, 2- -, and has the following structural formula: Aspirin, USP is an odor free white needle-like crystalline or fine-grained substance. When exposed to dampness, aspirin hydrolyzes into salicylic and acetic acids, and emits a vinegary odor.

* Please keep in mind that all text is summarized by machine, we do not bear any responsibility, and you should always check original source before taking any actions

** If you believe that content on the Plex is summarised improperly, please, contact us, and we will get rid of it quickly; please, send an email with a brief explanation.

*** If you want us to remove all links leading to your domain from and never use your website as a source of the "Online Knowledge", please contact us using a corporate email and we will remove everything in 10 business days.


Plex Page is a Biology & Health Sciences "Online Knowledge Base," where a machine summarizes all the summaries.